0
Original Research |

Non-Malignant Pleural Effusions (NMPE): a prospective study of 356 consecutive unselected patients

Steven P. Walker, MBChB; Anna J. Morley, BSc; Louise Stadon, BSc; Duneesha De Fonseka, MBChB; David A. Arnold, MBChB; Andrew RL. Medford, DM FRCP FCCP; Nick A. Maskell, DM FRCP FCCP
Author and Funding Information

Study was performed at Southmead Hospital, Southmead Road, Westbury-on-Trym, Bristol, BS10 5NB

The authors report no conflicts of interest, or personal or financial support or author involvement with organisation(s) with financial interest in the subject matter.

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom

North Bristol Lung Centre, Southmead Hospital, Bristol, United Kingdom

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom


Copyright 2016, . All Rights Reserved.


Chest. 2016. doi:10.1016/j.chest.2016.12.014
Text Size: A A A
Published online

Abstract

Background  Pleural effusions secondary to a non-malignant aetiology can represent significant morbidity and mortality. These non-malignant pleural effusions (NMPE) are common, with congestive heart failure (CHF) representing the leading cause. Despite this, there is limited data on mortality risk and the factors which influence them.

Methods  We recruited 782 consecutive patients presenting to a pleural service, between 03/2008 and 03/2015, with an undiagnosed pleural effusion. Further analysis was conducted on the 356 patients with NMPE. Pleural biochemistry, cytology, thoracic USS and chest radiograph were performed. Echocardiogram, CT scans, radiology-guided biopsy and medical thoracoscopy were undertaken as clinically indicated. Patients were followed-up for a minimum duration of 12 months with final diagnosis decided by independent review by 2 respiratory consultants.

Results  Of the 782 patients, 356(46%) were diagnosed with a NMPE. These patients had a mean age of 68(SD17) with 69% of patients male. Cardiac, renal and liver failure patients had 1-year mortality rates of 50%, 46% and 25% respectively. Bilateral effusions (HR 3.55 CI 2.22-5.68) and transudative effusions (HR 2.78 CI 1.81-4.28) were associated with a worse prognosis in patients with NMPE, with a 57% and 43% 1-year mortality respectively.

Conclusions  This is the largest prospectively collected series in patients with NMPE, demonstrating that those secondary to organ dysfunction have an extremely high 1-year mortality. In addition, the presence of bilateral and transudative effusions are an indicator of increased mortality. Clinicians should be aware of these poor prognostic features and guide management accordingly.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543